Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

NCT07421700 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Cancer
Advanced/Metastatic Urothelial Cancer
Urothelial Carcinoma

Interventions

BIOLOGICAL: PF-08634404
BIOLOGICAL: Enfortumab Vedotin

Sponsor

Pfizer

Collaborators

[object Object]